MIDATECH PHARMA
Investors | Contacts

Midatech Pharma Plc

Jim Phillips, Chief Executive Officer
Nick Robbins-Cherry, Finance Director
Tel: +44 (0)1235 888300
Email: ir@midatechpharma.com

Registered Office and Trading Address:
65 Innovation Drive
Milton Park
Abingdon
Oxfordshire OX14 4RQ
United Kingdom

Consilium Strategic Communications

Mary-Jane Elliott, Ivar Milligan, Matthew Neal, Hendrik Thys
Tel: +44 (0)20 3709 5700
Email: Midatech@consilium-comms.com

Westwicke Partners  - BOSTON, US

Chris Brinzey/ Lauren Shaughnessy
Email: Chris.Brinzey@westwicke.com
132 Chief Justice Cushing Highway
Cohasset, MA 02025 | (339) 970-2843

 

Enquiries from existing investors relating to shareholder records and share transfers should be directed to:

Neville Registrars Limited

Neville House
18 Laurel Lane
Halesowen B63 3DA
United Kingdom
Tel: +44 121 585 1131
Email: info@nevilleregistrars.co.uk

Neville Registrars are only able to deal with enquiries from existing investors and are not able to respond to requests to purchase shares in Midatech Pharma plc.

 

 

Investors
Contacts

Midatech Pharma Plc

Jim Phillips, Chief Executive Officer
Nick Robbins-Cherry, Finance Director
Tel: +44 (0)1235 888300
Email: ir@midatechpharma.com

Registered Office and Trading Address:
65 Innovation Drive
Milton Park
Abingdon
Oxfordshire OX14 4RQ
United Kingdom

Consilium Strategic Communications

Mary-Jane Elliott, Ivar Milligan, Matthew Neal, Hendrik Thys
Tel: +44 (0)20 3709 5700
Email: Midatech@consilium-comms.com

Westwicke Partners  - BOSTON, US

Chris Brinzey/ Lauren Shaughnessy
Email: Chris.Brinzey@westwicke.com
132 Chief Justice Cushing Highway
Cohasset, MA 02025 | (339) 970-2843

 

Enquiries from existing investors relating to shareholder records and share transfers should be directed to:

Neville Registrars Limited

Neville House
18 Laurel Lane
Halesowen B63 3DA
United Kingdom
Tel: +44 121 585 1131
Email: info@nevilleregistrars.co.uk

Neville Registrars are only able to deal with enquiries from existing investors and are not able to respond to requests to purchase shares in Midatech Pharma plc.

 

 

© Copyright 2017 Midatech Pharma PLC